Fundraising Fox
Pi Cardia
Founded 2009 · 95 employees on LinkedIn · 6 known investors
Find your way into Pi Cardia
Sign up to see every warm intro you have to Pi Cardia
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Pi Cardia team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Pi-Cardia develops non-implant-based, catheter-delivered devices for treating structural heart disease, including its ShortCut product for leaflet modification. The devices use a transfemoral, low-profile catheter approach aimed at short procedures and hospitalization for cardiac patients.
Founders & leadership
Pi Cardia was founded in 2009 by Erez Golan.
Investors · 6
How we know: Accelmed Partners's portfolio page · Not right? Tell us
How we know: Indaco Venture Partners's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Kreos Capital's portfolio page · Not right? Tell us
How we know: Sofinnova Partners's portfolio page · a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us
Founder mafia
2 people who came through Pi Cardia went on to found or lead other companies.
Frequently asked questions
- What does Pi Cardia do?
- Pi-Cardia develops non-implant-based, catheter-delivered devices for treating structural heart disease, including its ShortCut product for leaflet modification. The devices use a transfemoral, low-profile catheter approach aimed at short procedures and hospitalization for cardiac patients.
- Who founded Pi Cardia?
- Pi Cardia was founded by Erez Golan in 2009.
- Who are Pi Cardia's investors?
- Pi Cardia's investors include Accelmed Partners, Clal Biotechnology Industries, Indaco Venture Partners, Kreos Capital, Sofinnova Partners, Innogest Capital.